Fosaprepitant Accord Healthcare

Fosaprepitant Accord Healthcare is an intravenous medication used to prevent nausea and vomiting caused by chemotherapy. It belongs to a class of drugs known as neurokinin-1 (NK-1) receptor antagonists.

Fosaprepitant is primarily used to prevent nausea and vomiting in patients undergoing chemotherapy. It works by blocking substances in the body that can trigger these symptoms. This medication is often prescribed for patients who are receiving highly emetogenic chemotherapy, which is known to cause severe nausea and vomiting.

Fosaprepitant may cause common side effects such as fatigue, headache, and diarrhea. Some patients may also experience changes in taste or constipation. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Fosaprepitant should be used with caution in patients with a history of liver disease. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Pregnant women and those planning to become pregnant should discuss the risks and benefits with their doctor.

Fosaprepitant may interact with other medications, including those metabolized by the liver. It is important to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always consult your healthcare provider before starting or stopping any medication.